Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) or familial hibernian fever: Presentation in a four-day-old infant

Journal of Clinical Rheumatology

Volumn 14, Issue 6, 2008, Pages 342-345

  Savage, Tim ^a   Loftus, Brendan G ^a   Tormey, Vincent ^b   McDermott, Michael F ^c   Moylett, Edina ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Etanercept; Periodic fever; TNF receptor associated periodic syndrome

Indexed keywords

ANTIBIOTIC AGENT; STEROID; TNFRSF1A PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; CASE REPORT; CLINICAL FEATURE; FAMILY HISTORY; FLUID RESUSCITATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INFANT; LABORATORY TEST; LUMBAR PUNCTURE; MALE; PRIORITY JOURNAL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; FAMILIAL MEDITERRANEAN FEVER; FEVER; GENETICS; MISSENSE MUTATION; NEWBORN; PEDIGREE; RASH;

EXANTHEMA; FAMILIAL MEDITERRANEAN FEVER; FEVER; HUMANS; INFANT, NEWBORN; MALE; MUTATION, MISSENSE; PEDIGREE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 64149100886     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31817d109b     Document Type: Article

References (20)

1. Galon J, Aksentijevich I, McDermott MF, et al. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol. 2000;12:479-486.
2. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999; 97:133-144.
3. Williamson LM, Hull D, Mehta R, et al. Familial Hibernian Fever. Q J Med. 1982;51:469-480.
4. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol. 2005;17:586-599.
5. Drewe E, Huggins ML, Morgan AG, et al. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford). 2004;43:1405-1408.
6. Drewe E, McDermott EM, Powell PT, et al. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford). 2003;42:235-239.
7. Takagi K, Kawaguchi Y, Fujikawa S, et al. Tumor necrosis factor receptor-associated periodic syndrome with a C30R mutation in a Japanese family. Mod Rheumatol. 2007;17:265-266.
8. Dinc A, Erdem H, Rowczenio D, et al. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family. J Nephrol. 2005;18: 626-629.
9. Mulley J, Saar K, Hewitt G, et al. Gene localization for an autosomal dominant familial periodic fever to 12p13. Am J Hum Genet. 1998;62: 884-889.
10. McDermott MF, Ogunkolade BW, McDermott EM, et al. Linkage of familial Hibernian fever to chromosome 12p13. Am J Hum Genet. 1998;62:1446-1451.
11. Hull KM, Drewe E, Aksentijevich I, et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002;81:349-368.
12. Aganna E, Hammond L, Hawkins PN, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632-2644.
13. Federici L, Rittore-Domingo C, Koné-Paut I, et al. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis. 2006;65:1427-1432.
14. Aksentijevich I, Galon J, Soares M, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001;69: 301-314.
15. D'Osualdo A, Picco P, Caroli F, et al. MVK mutations and clinical features in Italian patients affected with autoinflammatory disorders. Eur J Hum Genet. 2005;13:314-320.
16. Siebert S, Amos N, Fielding CA, et al. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum. 2005;52:1287-1292.
17. Kimberley FC, Lobito AA, Siegel RM, et al. Falling into TRAPS- receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther. 2007;9:217.
18. Masson C, Simon V, Hoppé E, et al. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine. 2004;71:284-290.
19. Dodé C, Cuisset L, Dewlpech M, et al. TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis. J Nephrol. 2003;16:435-437.
20. Kallinich T, Briese S, Roesler J, et al. Two familial cases with tumour necrosis receptor-associated periodic syndrome caused by a non-cys-teine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis. J. Rheumatol. 2004;31:2519-2522.